Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China
· Delayed Price · Currency is CNY 17.15
+0.07 (0.41%)
Apr 30, 2026, 11:30 AM CST
SHA:605077 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 202.7 | 268.48 | 371.45 | 319.28 | 236.71 | Upgrade
|
| Depreciation & Amortization | 292.27 | 200.42 | 172.84 | 106.48 | 85.22 | Upgrade
|
| Other Amortization | 18.13 | 13.82 | 8.68 | 6.83 | 6.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.1 | 0.14 | 0.01 | -0.03 | -0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 20.04 | 0.49 | 4.27 | 2.31 | 5.58 | Upgrade
|
| Loss (Gain) From Sale of Investments | -16.57 | -22.44 | -11.69 | -33.16 | -51.93 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 18.62 | 0.17 | 6.89 | - | Upgrade
|
| Other Operating Activities | 96.6 | 22.36 | 21.77 | -1.35 | 6.45 | Upgrade
|
| Change in Accounts Receivable | -321.3 | -393.33 | 14.25 | -159.75 | -40.49 | Upgrade
|
| Change in Inventory | -90.02 | -410.94 | -20.14 | -161.1 | -75 | Upgrade
|
| Change in Accounts Payable | 234.47 | 451.3 | 51.5 | 161.12 | 86.9 | Upgrade
|
| Change in Other Net Operating Assets | 8.9 | 24.61 | 3 | - | 8.1 | Upgrade
|
| Operating Cash Flow | 424.4 | 146.5 | 619.47 | 271.98 | 264.32 | Upgrade
|
| Operating Cash Flow Growth | 189.70% | -76.35% | 127.77% | 2.90% | -21.15% | Upgrade
|
| Capital Expenditures | -483.38 | -1,430 | -690.7 | -539.75 | -360.93 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.06 | 0.42 | 1.2 | 11.77 | 0.56 | Upgrade
|
| Cash Acquisitions | - | -53.02 | -528.88 | -21 | -47.17 | Upgrade
|
| Divestitures | - | - | - | - | 17.5 | Upgrade
|
| Investment in Securities | -186.3 | -9.5 | - | 47.27 | -890 | Upgrade
|
| Other Investing Activities | 118.64 | -94.3 | -40.18 | 565.63 | 25.09 | Upgrade
|
| Investing Cash Flow | -548.97 | -1,586 | -1,259 | 63.92 | -1,255 | Upgrade
|
| Long-Term Debt Issued | 1,487 | 682.41 | 2,328 | 696.7 | 156.07 | Upgrade
|
| Long-Term Debt Repaid | -669.32 | -798.78 | -490.23 | -192.88 | -182.89 | Upgrade
|
| Net Debt Issued (Repaid) | 817.68 | -116.37 | 1,838 | 503.82 | -26.82 | Upgrade
|
| Issuance of Common Stock | - | 7.72 | 77.37 | - | 1,394 | Upgrade
|
| Common Dividends Paid | -253.47 | -196.56 | -173.09 | -111.94 | -120.34 | Upgrade
|
| Other Financing Activities | -506.89 | -5.34 | - | - | -26.9 | Upgrade
|
| Financing Cash Flow | 57.32 | -310.54 | 1,742 | 391.88 | 1,220 | Upgrade
|
| Foreign Exchange Rate Adjustments | 5.86 | 10.67 | 0.86 | 5.02 | -1.94 | Upgrade
|
| Net Cash Flow | -61.39 | -1,739 | 1,104 | 732.8 | 227.74 | Upgrade
|
| Free Cash Flow | -58.98 | -1,283 | -71.23 | -267.77 | -96.61 | Upgrade
|
| Free Cash Flow Margin | -1.41% | -45.69% | -2.56% | -12.17% | -6.06% | Upgrade
|
| Free Cash Flow Per Share | -0.19 | -3.39 | -0.24 | -0.90 | -0.34 | Upgrade
|
| Cash Interest Paid | - | 2.6 | - | - | - | Upgrade
|
| Cash Income Tax Paid | -42.29 | -132.84 | -45.42 | -95.23 | 3.57 | Upgrade
|
| Levered Free Cash Flow | -346.96 | -1,084 | -251.85 | -336.7 | -233.82 | Upgrade
|
| Unlevered Free Cash Flow | -346.96 | -1,063 | -228.63 | -327.8 | -231.38 | Upgrade
|
| Change in Working Capital | -188.68 | -353.32 | 47.46 | -135.89 | -23.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.